VDR and prostate cancer: Further support for a possible influence of vitamin D on prognosis comes from studies showing that genetic variants in the vitamin D receptor are associated with Gleason score [14], and genetic variants in the vitamin D pathway are associated with risk of recurrence or progression and prostate cancer-specific mortality [15].